• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Lewis Sara Grootwassink was granted 10,657 shares, increasing direct ownership by 30% to 46,744 units (SEC Form 4)

    4/29/25 5:06:09 PM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate
    Get the next $DOC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Lewis Sara Grootwassink

    (Last) (First) (Middle)
    4600 SOUTH SYRACUSE STREET
    SUITE 500

    (Street)
    DENVER CO 80237

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HEALTHPEAK PROPERTIES, INC. [ DOC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/25/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/25/2025 A 10,657(1) A $0 46,744 D
    Common Stock 22,000 I Trust
    Common Stock 9,000 I IRA
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Restricted stock units vest in full on the earlier of the first anniversary of the April 25, 2025 grant date or the Company's next annual meeting of stockholders.
    Remarks:
    Exhibit List: Exhibit 24 - Power of Attorney
    Carol Samaan, SVP, Legal (Attorney-In-Fact) 04/29/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DOC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOC

    DatePrice TargetRatingAnalyst
    1/15/2025$25.00Equal-Weight → Overweight
    Morgan Stanley
    10/21/2024$20.00 → $28.00Hold → Buy
    Deutsche Bank
    5/3/2024Neutral → Outperform
    Wedbush
    4/26/2024$19.00 → $21.00Neutral → Outperform
    Exane BNP Paribas
    4/22/2024$22.00Buy
    Mizuho
    4/1/2024$18.00 → $25.00Underperform → Buy
    BofA Securities
    3/25/2024$19.00Equal Weight
    Wells Fargo
    3/8/2024$21.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $DOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Healthpeak Properties upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Healthpeak Properties from Equal-Weight to Overweight and set a new price target of $25.00

      1/15/25 7:33:36 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Healthpeak Properties from Hold to Buy and set a new price target of $28.00 from $20.00 previously

      10/21/24 7:38:33 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate
    • Healthpeak Properties upgraded by Wedbush

      Wedbush upgraded Healthpeak Properties from Neutral to Outperform

      5/3/24 7:31:37 AM ET
      $DOC
      Real Estate Investment Trusts
      Real Estate